Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the ...

Paris: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) ...

The study was funded by Amgen. Stone has reported being a consultant for Amgen, Zenas, Argenx, Bristol Myers Squibb, Novartis ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by ...

Medical experts have raised concerns over the soaring costs and scarcity of diabetes medications in Nigeria. They also revealed that the number of individuals living with diabetes in the country has ...

Health stocks tumbled as vaccine sceptic RFK Jr. was named by President-elect Trump to head the Department of Health and ...

Increasing global temperatures wrought by greenhouse gas emissions have boosted the number of dengue cases, new research ...

No fewer than 10 companies have shut down or relocated their operations from Nigeria due to the current economic challenges, ...

Paris-listed Sanofi, a producer of flu vaccines, slid 4.4% to hit a four-month low. Overnight, Asian stocks were mostly ...

The banks have been quietly celebrating. The oil and gas giants are preparing fresh investment plans. The tech giants have ...

Last week saw US pharma major AbbVie release disappointing Phase II trial results on its emraclidine in schizophrenia, which ...

US antiviral giant Gilead Sciences on Friday unveiled two-and-a-half-year interim analysis from the ongoing Phase III ASSURE ...